1. Home
  2. STTK vs QNC Comparison

STTK vs QNC Comparison

Compare STTK & QNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.90

Market Cap

538.3M

Sector

Health Care

ML Signal

HOLD

QNC

Quantum eMotion Corp. Common Shares

N/A

Current Price

$2.96

Market Cap

434.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
STTK
QNC
Founded
2016
2007
Country
United States
Canada
Employees
N/A
5
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.3M
434.7M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
STTK
QNC
Price
$6.90
$2.96
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
05-01-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.90
52 Week High
$8.33
$3.59

Technical Indicators

Market Signals
Indicator
STTK
QNC
Relative Strength Index (RSI) 64.10 46.82
Support Level $5.81 $2.63
Resistance Level $7.68 $3.01
Average True Range (ATR) 0.58 0.24
MACD 0.28 -0.03
Stochastic Oscillator 84.39 9.42

Price Performance

Historical Comparison
STTK
QNC

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About QNC Quantum eMotion Corp. Common Shares

Quantum eMotion Inc is dedicated to developing of a new generation of quantum-safe encryption for the quantum computing age. It is a developer of a new generation of cryptographic solutions under the acquisition of licenses. It allows clients and partners to develop secure quantum-safe encryption that can protect anything from consumer and enterprise devices like mobile phones, computers, the Internet of Things, and networking equipment to demanding cloud-based applications, servers, and military devices.

Share on Social Networks: